Literature DB >> 11751630

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

E L Jackson1, N Willis, K Mercer, R T Bronson, D Crowley, R Montoya, T Jacks, D A Tuveson.   

Abstract

Adenocarcinoma of the lung is the most common form of lung cancer, but the cell of origin and the stages of progression of this tumor type are not well understood. We have developed a new model of lung adenocarcinoma in mice harboring a conditionally activatable allele of oncogenic K-ras. Here we show that the use of a recombinant adenovirus expressing Cre recombinase (AdenoCre) to induce K-ras G12D expression in the lungs of mice allows control of the timing and multiplicity of tumor initiation. Through the ability to synchronize tumor initiation in these mice, we have been able to characterize the stages of tumor progression. Of particular significance, this system has led to the identification of a new cell type contributing to the development of pulmonary adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751630      PMCID: PMC312845          DOI: 10.1101/gad.943001

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  24 in total

1.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.

Authors:  L Johnson; K Mercer; D Greenbaum; R T Bronson; D Crowley; D A Tuveson; T Jacks
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

2.  Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes.

Authors:  T Kobayashi; H Tsuda; M Noguchi; S Hirohashi; Y Shimosato; T Goya; Y Hayata
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

Review 3.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

4.  Surfactant protein C expression in urethane-induced murine pulmonary tumors.

Authors:  R J Mason; M Kalina; L D Nielsen; A M Malkinson; J M Shannon
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Cells of origin of primary pulmonary neoplasms in mice: morphologic and histochemical studies.

Authors:  L G Thaete; A M Malkinson
Journal:  Exp Lung Res       Date:  1991 Mar-Apr       Impact factor: 2.459

6.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

7.  Cytodifferentiation of the nonciliated bronchiolar epithelial (Clara) cell during rabbit lung maturation: an ultrastructural and morphometric study.

Authors:  C G Plopper; J L Alley; C J Serabjitsingh; R M Philpot
Journal:  Am J Anat       Date:  1983-07

8.  Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice.

Authors:  K A Wikenheiser; J C Clark; R I Linnoila; M T Stahlman; J A Whitsett
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

9.  Expression of alveolar type II cell markers in acinar adenocarcinomas and adenoid cystic carcinomas arising from segmental bronchi. A study in a heterotopic bronchogenic carcinoma model in dogs.

Authors:  A A TenHave-Opbroek; W G Hammond; J R Benfield; R L Teplitz; J H Dijkman
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

10.  Origin of bronchioloalveolar carcinoma and peripheral bronchial adenocarcinoma.

Authors:  G B Dermer
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

View more
  954 in total

Review 1.  Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras.

Authors:  Anica Wandler; Kevin Shannon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 2.  Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets.

Authors:  Matthias Drosten; Carmen Guerra; Mariano Barbacid
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

3.  Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions.

Authors:  Geou-Yarh Liou; Heike Döppler; Brian Necela; Brandy Edenfield; Lizhi Zhang; David W Dawson; Peter Storz
Journal:  Cancer Discov       Date:  2014-10-31       Impact factor: 39.397

Review 4.  Developing therapeutic microRNAs for cancer.

Authors:  A G Bader; D Brown; J Stoudemire; P Lammers
Journal:  Gene Ther       Date:  2011-06-02       Impact factor: 5.250

5.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

6.  Contrast agents for quantitative microCT of lung tumors in mice.

Authors:  Kush Lalwani; Anand Giddabasappa; Danan Li; Peter Olson; Brett Simmons; Farbod Shojaei; Todd Van Arsdale; James Christensen; Amy Jackson-Fisher; Anthony Wong; Patrick B Lappin; Jeetendra Eswaraka
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

7.  Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.

Authors:  Cornelia Johanna Franziska Scheitz; Tae Seung Lee; David James McDermitt; Tudorita Tumbar
Journal:  EMBO J       Date:  2012-10-02       Impact factor: 11.598

Review 8.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

9.  Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.

Authors:  Kate D Sutherland; Ji-Ying Song; Min Chul Kwon; Natalie Proost; John Zevenhoven; Anton Berns
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

10.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.